Market Cap: $34.12B
Market Cap: $34.12B
Open
$212.59
Prev. Close
$237.85
High
$220.46
Low
$211.88
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions.
ResMed Inc. trades on the New York Stock Exchange under the ticker RMD, priced in USD.
ResMed Inc. has a market capitalisation of $34.12B, based on its latest share price.
RMD trades at 21.41 times its trailing 12-month earnings.
Over the past 52 weeks RMD has traded between $180.27 and $277.67.
Yes. ResMed Inc.'s dividend yields 1.05% at the current share price, paying out 39% of its earnings.
Highly profitable: keeps 27.8% of revenue as net profit.
The analyst consensus rating for RMD is Hold. Analysts' average 12-month price target of $272.96 implies 13% upside.
Michael J. Farrell is the CEO of ResMed Inc., which is headquartered in San Diego.
Generated automatically from reported financial data. General information only, not financial advice.

Recently, ResMed (Ticker: RMD) confronts a dual-edged challenge as emerging competitive pressures jeopardize its stronghold in the sleep-apnea market. Analysts spotlight the potential for short-sellin…

ResMed (Ticker: RMD) announces a groundbreaking partnership with Oura, a leader in sleep-tracking technology, to revolutionize the management of sleep health. This collaboration signifies a strategic…
ResMed Expands Its Presence in the Sleep Apnea Market with Innovative Solutions ResMed, a leader in cloud-connected devices and solutions for sleep apnea and chronic obstructive pulmonary disease (COP…
ResMed Leverages Innovation to Enhance Patient Care Amid Industry Challenges ResMed, a leader in cloud-connected devices for people with sleep apnea and chronic obstructive pulmonary disease (COPD), c…